| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/06/1997 | WO1997003692A1 A stabilized pharmaceutical formulation comprising a growth hormone pre-treated with zinc and optionally lysine or calcium ions |
| 02/06/1997 | WO1997003688A1 Pharmaceutical compositions containing protein |
| 02/06/1997 | WO1997003685A1 Laxative/antidiarrheal composition comprising polyethylene glycol and fiber bulking agent |
| 02/06/1997 | WO1997003673A1 Sustained-release formulation of d-threo-methylphenidate |
| 02/06/1997 | WO1997003670A1 Paroxetine controlled release compositions |
| 02/06/1997 | WO1997003662A1 Pharmaceutical composition of l-dopa ethyl ester |
| 02/06/1997 | WO1997003658A2 Use of aromas and flavours to induce or change eating patterns |
| 02/06/1997 | WO1997003657A1 A process for preparing microparticles through phase inversion phenomena |
| 02/06/1997 | WO1997003656A1 Granular preparation and process for producing the same |
| 02/06/1997 | WO1997003655A1 Stable clear solutions of non-steroidal anti-inflammatory drugs for incorporation into gelatin capsules |
| 02/06/1997 | WO1997003654A2 Pharmaceutical compositions |
| 02/06/1997 | WO1997003653A1 Enterogenin pharmaceutical form |
| 02/06/1997 | WO1997003652A1 Epidural administration of therapeutic compounds with sustained rate of release |
| 02/06/1997 | WO1997003651A1 Lipid vehicle drug delivery composition containing vitamin e |
| 02/06/1997 | WO1997003650A1 Ionophore antibiotic formulations |
| 02/06/1997 | WO1997003649A1 Improvements in and relating to powders for use in dry powder inhalers |
| 02/06/1997 | WO1997003645A1 Cosmetic body care composition in the form of an oil-in-water emulsion |
| 02/06/1997 | WO1997003644A1 Reverse gels comprising a continuous fluorinated phase |
| 02/06/1997 | WO1997003643A1 Sunscreen compositions |
| 02/06/1997 | WO1997003629A1 Drug delivery compositions for improved stability of steroids |
| 02/06/1997 | WO1996040083A3 Methods and compositions for preparing soft gelatin capsules having shells resistant to permeation by fill materials |
| 02/06/1997 | WO1996040074A3 Device for releasing aggregation-stabilized, biologically active agent |
| 02/06/1997 | WO1996036314A3 Method for drug delivery to the pulmonary system |
| 02/06/1997 | DE19528524A1 Calciumhaltiges Mittel zur intestinalen Phosphatbindung und Verfahren zu seiner Herstellung Calcium-containing phosphate binding agents for intestinal and process for its preparation |
| 02/06/1997 | DE19528029A1 Magnetische Polymerpartikel auf der Basis von Polyvinylalkohol, Verfahren für ihre Herstellung und Verwendung Magnetic polymer particles based on polyvinyl alcohol, processes for their preparation and use |
| 02/06/1997 | DE19527925A1 Transdermales therapeutisches System mit einer trennmittelbeschichteten Schutzschicht Transdermal therapeutic system with a release coated protective layer |
| 02/06/1997 | CA2227744A1 Reverse gels comprising a continuous fluorinated phase |
| 02/06/1997 | CA2227538A1 Hormone patch |
| 02/06/1997 | CA2227373A1 Novel amide-based cationic lipids |
| 02/06/1997 | CA2227287A1 A method for gene therapy using nucleic acid loaded polymeric microparticles |
| 02/06/1997 | CA2227208A1 Pharmaceutical composition of l-dopa ethyl ester |
| 02/06/1997 | CA2227065A1 Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunity |
| 02/06/1997 | CA2227013A1 Compounds and methods for treatment of egf receptor associated cancers and purification of the egf receptor |
| 02/06/1997 | CA2226523A1 A stabilized pharmaceutical formulation comprising a growth hormone pre-treated with zinc and optionally lysine or calcium ions |
| 02/06/1997 | CA2224734A1 Lipid vehicle drug delivery composition containing vitamin e |
| 02/06/1997 | CA2200295A1 Enterogenin pharmaceutical form |
| 02/05/1997 | EP0757049A1 Camptothecin derivatives |
| 02/05/1997 | EP0756870A2 Pharmaceutical compositions for topic use on the basis of ketoprofen |
| 02/05/1997 | EP0756868A2 Aerosol compositions |
| 02/05/1997 | EP0756862A1 Use of bradykinine antagonist in a cosmetic, pharmaceutical or dermatological composition and the composition obtained |
| 02/05/1997 | EP0756827A2 Composition for nutrition |
| 02/05/1997 | EP0756820A2 Compositions comprising an iodosphor of Poly-N-vinyllactam and dextrin and usetheref |
| 02/05/1997 | EP0756491A1 Use of brain natriuretic peptides (bnp), phosphorylated urodilatine, phosphorylated cdd/anp and combinations thereof |
| 02/05/1997 | EP0756489A1 Cyclosporin containing composition and process for the preparation thereof |
| 02/05/1997 | EP0756487A1 Method for implanting encapsulated cells in a host |
| 02/05/1997 | EP0756484A1 Wet granulation formulation for bisphosphonic acids |
| 02/05/1997 | EP0756482A1 Transdermal delivery of alpha adrenoceptor blocking agents |
| 02/05/1997 | EP0756480A1 Sustained-release matrix pellets and method for preparing them |
| 02/05/1997 | EP0756479A1 Gentle anti-acne composition |
| 02/05/1997 | EP0579830B1 Therapeutic agent for corneal lesion |
| 02/05/1997 | EP0474647B1 Method and device for the release of drugs to the skin |
| 02/05/1997 | CN1142190A Method and device for the provocation of air passage narrowing and/or the induction of sputum |
| 02/05/1997 | CN1142182A Granular product or tablet containing an effervescent system and an active pharmaceutical substance, as well as a method for its preparation |
| 02/05/1997 | CN1141808A Interferon solution |
| 02/05/1997 | CN1141800A Eyedrops for treatment of cataract and production technology thereof |
| 02/05/1997 | CN1141797A Tincture for treatment of toothache |
| 02/05/1997 | CN1141796A Plaster for treatment of bronchial asthma |
| 02/05/1997 | CN1141795A Plaster for treatment of various scald |
| 02/05/1997 | CN1141794A Plaster for treatment of hyperosteogeny |
| 02/05/1997 | CN1141793A Plaster for treatment of bone tuberculosis and lymphoid tuberculosis |
| 02/05/1997 | CN1141791A Ointment for treatment of bone tuberculosis |
| 02/05/1997 | CN1141774A Formular of medicine for preventing and curing eczema resulted from baby's napkin |
| 02/05/1997 | CN1141767A Medical product containing organic ash content capable of emitting far infrared |
| 02/04/1997 | US5600035 Photoresists; polymer monomers |
| 02/04/1997 | US5599891 Crystallisable, biodegradable polyhydroxyalkanoate, having on their surface a phopholipid or a surfactant |
| 02/04/1997 | US5599852 Polylactone homo- and copolymers |
| 02/04/1997 | US5599824 Pharmaceutical preparation containing a specific crystal modification of isopropyl-(2-methoxyethyl) 1,4-dihydro-2, 6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate |
| 02/04/1997 | US5599808 Aqueous indolocarbazole solutions |
| 02/04/1997 | US5599800 High viscosity oil in water emulsion having polysiloxane in oil phase |
| 02/04/1997 | US5599798 Cyclic AMP derivative-containing ointment |
| 02/04/1997 | US5599788 Wound healing agents; dermal fibroplast adhesion promoter |
| 02/04/1997 | US5599577 Drug delivery; gastrointestinal disorders |
| 02/04/1997 | US5599557 Stable hydrated cephalosporin dry powder for oral suspension formulation |
| 02/04/1997 | US5599556 Prolamine coatings for taste masking |
| 02/04/1997 | US5599555 Encapsulated cometic compositions |
| 02/04/1997 | US5599554 Treatment of nicotine craving and/or smoking withdrawal symptoms |
| 02/04/1997 | US5599553 Polycaprolactone film, active material; sustained release |
| 02/04/1997 | US5599552 Biodegradable polymer composition |
| 02/04/1997 | US5599551 Genital lubricants containing zinc as an anti-viral agent |
| 02/04/1997 | US5599535 Administering a non-steroidal antiinflammatory agent preventing cell lose in eye disorders |
| 02/04/1997 | US5599534 Reversible gel-forming composition for sustained delivery of bio-affecting substances, and method of use |
| 02/04/1997 | US5599533 Organopolysiloxane elastomer dispersion; cosmetics |
| 02/04/1997 | US5599528 Preventing discoloration and decomposition of kojic acid in aqueous cosmetic emulsions by adding nonionic surfactants and controlling hydrophilic-lipophilic balance |
| 02/04/1997 | US5599523 Echo contrast agent |
| 02/04/1997 | US5599388 Acid resistant calcium carbonate composition containing an aluminum salt, uses therefor and processes for its production |
| 02/04/1997 | US5599296 Apparatus and method of delivery of gas-supersaturated liquids |
| 02/04/1997 | CA2172603C Solid substances comprising valproic acid and sodium valproate |
| 02/04/1997 | CA2128199C Stable solid pharmaceutical compositions containing enalapril maleate |
| 02/04/1997 | CA2123332C Controlled release formulation of diltiazem hydrochloride |
| 02/04/1997 | CA2104045C Physical trapping type polymeric micelle drug preparation |
| 02/04/1997 | CA2071840C Method for producing protein microspheres |
| 02/04/1997 | CA2053190C Preparation of medicaments for treating asthma using (s)-o-fluoromethyl-histidine and esters thereof |
| 02/04/1997 | CA2043841C Large intestinal dissociative hard capsules |
| 02/04/1997 | CA2035693C Syrup composition |
| 02/04/1997 | CA1338889C Morphine containing composition |
| 02/01/1997 | CA2181933A1 Formulations containing an iodophore comprising poly-n-vinyl-lactam and dextrin and the use of such formulations |
| 01/30/1997 | WO1997002835A1 Intranasal vaccination against gastrointestinal disease |
| 01/30/1997 | WO1997002832A1 Lyophilized hgf preparations |
| 01/30/1997 | WO1997002831A1 Herbal compositions for hepatic disorders |
| 01/30/1997 | WO1997002812A2 Layered tablet for the controlled release of active substances |